Literature DB >> 3153328

New aspects of infantile oxalosis.

E P Leumann1, A Niederwieser, A Fanconi.   

Abstract

Infantile oxalosis is the most severe form of primary hyperoxaluria type I (PH I). Only 28 patients have been reported in detail; it was found that diagnosis was usually delayed, and most patients presented before the age of 4 months in renal failure and died within the 1st year of life. This report comprises two infants in whom diagnosis of PH I was made in the first few weeks of life before renal function was impaired. Case 1, whose brother had died of infantile oxalosis, already had greatly increased urinary oxalate and glycolate excretion at 7 days of age. In Case 2, PH I was diagnosed early because of the finding of increased renal echogenicity at 3 weeks of age; this patient had numerous episodes of stone formation despite continuous treatment with pyridoxine, but maintained renal function with normal serum creatinine levels at the age of 28 months. Prenatal diagnosis was attempted in case 1; however, amniotic fluid oxalate and glycolate concentrations were normal, suggesting that these acids pass the placenta and are not retained. The recent discovery of a transamination defect (deficiency of the peroxisomal enzyme alanine: glyoxylate aminotransferase) explains why some patients respond to pyridoxine treatment. Differences in onset and severity of PH I and in response to pyridoxine suggest that this disorder is biochemically and genetically heterogeneous.

Entities:  

Mesh:

Year:  1987        PMID: 3153328     DOI: 10.1007/bf00849265

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Deficiency of 2-oxo-glutarate: glyoxylate carboligase activity in primary hyperoxaluria.

Authors:  J Koch; E L Stokstad; H E Williams; L H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1967-04       Impact factor: 11.205

2.  Treatment of primary hyperoxaluria.

Authors:  C E Dent; T C Stamp
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

3.  Successful treatment of primary hyperoxaluria in neonate.

Authors:  G A Rose; L J Arthur; T L Chambers; G P Kasidas; I V Scott
Journal:  Lancet       Date:  1982-06-05       Impact factor: 79.321

4.  Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity.

Authors:  C J Danpure; P R Jennings; R W Watts
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

5.  Ultrasonic diagnosis of primary hyperoxaluria in infancy.

Authors:  J N Brennan; R V Diwan; S P Makker; B A Cromer; E M Bellon
Journal:  Radiology       Date:  1982-10       Impact factor: 11.105

Review 6.  Oxalosis in infancy.

Authors:  F E de Zegher; E D Wolff; A J vd Heijden; R N Sukhai
Journal:  Clin Nephrol       Date:  1984-09       Impact factor: 0.975

7.  Successful strategies for renal transplantation in primary oxalosis.

Authors:  J I Scheinman; J S Najarian; S M Mauer
Journal:  Kidney Int       Date:  1984-05       Impact factor: 10.612

8.  Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation.

Authors:  R W Watts; R Y Calne; R Williams; M A Mansell; N Veall; P Purkiss; K Rolles
Journal:  Q J Med       Date:  1985-10

9.  Primary hereditary oxalosis retinopathy.

Authors:  T A Zak; R Buncic
Journal:  Arch Ophthalmol       Date:  1983-01

10.  Primary hyperoxaluria: an important cause of renal failure in infancy.

Authors:  E P Leumann
Journal:  Int J Pediatr Nephrol       Date:  1985 Jan-Mar
View more
  10 in total

1.  Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT).

Authors:  A C Tarn; C von Schnakenburg; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.

Authors:  H Ruder; G Otto; R B Schutgens; U Querfeld; R J Wanders; K H Herzog; P Wölfel; S Pomer; K Schärer; G A Rose
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

3.  Urinary oxalate and glycolate excretion in healthy infants and children.

Authors:  E P Leumann; A Dietl; A Matasovic
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

4.  [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].

Authors:  M Frosch; E Kuwertz-Bröking; M Bulla; D B von Bassewitz; D B Leusmann
Journal:  Klin Wochenschr       Date:  1989-11-17

5.  Transplantation outcomes in primary hyperoxaluria.

Authors:  E J Bergstralh; C G Monico; J C Lieske; R M Herges; C B Langman; B Hoppe; D S Milliner
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

Review 6.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

7.  A clinicopathological study of ocular involvement in primary hyperoxaluria type I.

Authors:  K W Small; J Scheinman; G K Klintworth
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

Review 8.  Prenatal diagnosis of inborn errors of metabolism with renal manifestations.

Authors:  E Harms
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

Review 9.  Improving Treatment Options for Primary Hyperoxaluria.

Authors:  Bernd Hoppe; Cristina Martin-Higueras
Journal:  Drugs       Date:  2022-07-02       Impact factor: 11.431

10.  Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry.

Authors:  Lisa J Deesker; Sander F Garrelfs; Giorgia Mandrile; Michiel J S Oosterveld; Pierre Cochat; Georges Deschênes; Jérôme Harambat; Sally-Anne Hulton; Asheeta Gupta; Bernd Hoppe; Bodo B Beck; Laure Collard; Rezan Topaloglu; Larisa Prikhodina; Eduardo Salido; Thomas Neuhaus; Jaap W Groothoff; Justine Bacchetta
Journal:  Kidney Int Rep       Date:  2022-04-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.